It’s too soon for people to think they might be able to pick and choose among coronavirus vaccines, said Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases.
Even with Johnson & Johnson asking the Food and Drug Administration for emergency use authorization of its vaccine, there’s just not enough vaccine available, Fauci told CNN on Thursday.
"I don't think right in the beginning they will, because right now, the demand is far excess of the supply. So, people will, I think, gladly take whatever is available to them," Fauci said.
If the Johnson & Johnson vaccine wins an EUA, that would make three vaccine brands on the US market: Pfizer-BioNTech, Moderna, and Johnson & Johnson.
"As we get through February, into March, and April, and May, when the amount of vaccine becomes much more plentiful, there is certainly a possibility that people will know that this particular vaccine is maybe given in the pharmacies, and this you might get in a clinic, or in your doctor's office, or wherever. They could potentially have a choice," Fauci said.
The Pfizer and Moderna vaccines are very similar and require two doses. Johnson & Johnson’s vaccine uses a different approach and only needs one shot to work.